Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(20%)

Results Posted

50%(1 trials)

Phase Distribution

Ph phase_2

40%

Ph not_applicable

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

2(50.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Other(2)

Detailed Status

Completed2

unknown2

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 22 (50.0%)

N/A2 (50.0%)

Trials by Status

completed240%

active_not_recruiting120%

unknown240%

Recent Activity

1 active trials

Showing 5 of 5

active_not_recruitingnot_applicable

Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia

NCT05992077

completedphase_2

Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19

NCT04532931

completedphase_2

Clinical Trials (5)

Showing 5 of 5 trials

NCT05992077Not Applicable

Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia

Active Not Recruiting

NCT04532931Phase 2

Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19

Completed

NCT04561063Phase 2

COVID-19 Prophylaxis South Africa (COVER HCW)

Completed

NCT03646396Not Applicable

Effect of Sofosbuvir-daclatasuvir on Angiogenesis

Unknown

NCT02657694

Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5